Novartis Ag ADR
(NY:
NVS
)
110.53
+0.20 (+0.18%)
Official Closing Price
Updated: 4:10 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,142,039
Open
110.03
Bid (Size)
105.00 (1)
Ask (Size)
112.50 (5)
Prev. Close
110.33
Today's Range
110.01 - 110.62
52wk Range
92.19 - 112.48
Shares Outstanding
N/A
Dividend Yield
3.14%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Global Stocks to Buy to Escape the Volatility on Wall Street
Today 7:34 EDT
Discover three top global stocks as a smart hedge against Wall Street volatility, offering diversification and resilience in uncertain times.
Via
InvestorPlace
3 Spinoff Stocks You Should Buy Now: July 2024
July 15, 2024
Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early.
Via
InvestorPlace
Performance
YTD
+9.44%
+9.44%
1 Month
+5.34%
+5.34%
3 Month
+17.07%
+17.07%
6 Month
+2.64%
+2.64%
1 Year
+11.71%
+11.71%
More News
Read More
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
July 13, 2024
Via
InvestorPlace
3 Healthcare Stocks Injecting AI for Big Gains
July 13, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is NYSE:NVS a Good Fit for Dividend Investing?
July 12, 2024
Via
Chartmill
Exploring NYSE:NVS's dividend characteristics.
June 21, 2024
Via
Chartmill
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
July 15, 2024
Via
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Novartis Stock Generating Improved Relative Strength
July 08, 2024
Via
Investor's Business Daily
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
Via
Benzinga
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
Via
Investor's Business Daily
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Via
InvestorPlace
Mississippi Judge Upholds State Law Mandating Drug Discounts for Low-Income Patients
July 02, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Superlab Suisse opens state-of-the-art facility in Basel, fostering new spaces for scientific breakthroughs
June 25, 2024
Via
News Direct
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
June 25, 2024
Via
Investor's Business Daily
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Via
Benzinga
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
June 20, 2024
Via
Benzinga
What's Going On With Neurological Disease Focused Trevena On Thursday?
June 20, 2024
Via
Benzinga
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Via
InvestorPlace
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
Via
InvestorPlace
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
June 06, 2024
Via
Benzinga
Leigh Burgess, CEO & Founder Bold Industries Group, Announces Pre-Sale of New Book: Be BOLD Today
June 04, 2024
Via
Get News
The 3 Most Undervalued Healthcare Stocks to Buy in June 2024
June 04, 2024
Via
InvestorPlace
Novartis Sues to Block Maryland's New Drug Discount Law
May 31, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety
May 31, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.